Molecular mechanism underlying cAMP-induced amplification of IGF mitogenic activity through PI3-kinase binding protein, PI3KAP/XB130.

cAMP 通过 PI3 激酶结合蛋白 PI3KAP/XB130 诱导 IGF 有丝分裂活性放大的分子机制。

基本信息

  • 批准号:
    21580345
  • 负责人:
  • 金额:
    $ 3.16万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2009
  • 资助国家:
    日本
  • 起止时间:
    2009 至 2011
  • 项目状态:
    已结题

项目摘要

We previously demonstrated that long-term pretreatment of rat FRTL-5 thyroid cells with TSH or cAMP-generating reagents potentiated IGF-I-dependent DNA synthesis. Under this condition, cAMP treatment increased tyrosine phosphorylation of a 125 kDa protein(p125) and its association with a p85 regulatory subunit of phosphatidylinositol 3-kinase(p85 PI3K), which were suggested to be important for potentiation of DNA synthesis. This study was undertaken to identify p125 and to elucidate its roles in potentiation of DNA synthesis induced by IGF-I. Immunoprecipitated phosphotyrosyl p125 in cAMP-stimulated FRTL-5 cells, was shown by MALDI-TOF MS analysis, to be a rat orthologue of human XB130, which we named phosphatidylinositol 3-kinase-associated protein(PI3KAP). cAMP treatment elevated PI3KAP/XB130 mRNA and protein levels as well as tyrosine phosphorylation and PI3KAP/XB130 interaction with p85 PI3K, leading to increased PI3K activities. Importantly, PI3KAP/XB130 knockdown in FRTL-5 cells attenuated cAMP-dependent potentiation of IGF-I-induced DNA synthesis. Addition of Src family kinase inhibitors, PP1 or PP2, during cAMP treatment abolished tyrosine phosphorylation of PI3KAP/XB130 and its interaction with p85 PI3K. In addition, c-Src was associated with PI3KAP/XB130 and was activated in response to cAMP. Together, these data indicate that cAMP-dependent induction of PI3KAP/XB130 and its association with PI3K are required for enhancement of IGF mitogenic activities.
我们先前证明,用TSH或营地生成试剂对大鼠FRTL-5甲状腺细胞进行长期预处理增强了IGF-I依赖性DNA合成。在这种情况下,cAMP处理增加了125 kDa蛋白(P125)的酪氨酸磷酸化及其与磷脂酰肌醇3-激酶(P85 PI3K)的P85调节亚基的关联,这被认为对增强DNA合成的增强很重要。这项研究是为了鉴定P125并阐明其在IGF-I诱导的DNA合成增强中的作用。通过MALDI-TOF MS分析显示,在cAMP刺激的FRTL-5细胞中,免疫沉淀的磷酸酪糖基P125是人XB130的大鼠直系同源物,我们将其命名为磷脂酰肌醇3-激酶与磷脂型蛋白质酶相关蛋白(PI3KAP)。 CAMP处理升高PI3KAP/XB130 mRNA和蛋白质水平以及酪氨酸磷酸化和PI3KAP/XB130与P85 PI3K的相互作用,从而导致PI3K活性增加。重要的是,FRTL-5细胞中的PI3KAP/XB130敲低抑制了IGF-I诱导的DNA合成的CAMP依赖性增强。在营地治疗期间,添加了SRC家族激酶抑制剂PP1或PP2,废除了PI3KAP/XB130的酪氨酸磷酸化及其与P85 PI3K的相互作用。此外,C-SRC与PI3KAP/XB130相关,并因cAMP而被激活。总之,这些数据表明PI3KAP/XB130的cAMP依赖性诱导及其与PI3K的关联是增强IGF有丝分裂活性所必需的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
GH or IGF-I represses 11beta-hydroxysteroid dehydrogenase type 1(HSD1)mRNA expression in 3T3-L1 and its activity in their homogenates.
GH 或 IGF-I 抑制 3T3-L1 中 11β-羟基类固醇脱氢酶 1 型 (HSD1) mRNA 表达及其匀浆中的活性。
  • DOI:
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Morita J;Hakuno F;Hizuka N;Takahashi SI;Takano K
  • 通讯作者:
    Takano K
Dietary protein deprivation upregulates insulin signaling and inhibits gluconeogenesis in rat liver
  • DOI:
    10.1677/jme-10-0102
  • 发表时间:
    2010-11-01
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Toyoshima, Yuka;Tokita, Reiko;Takahashi, Shin-Ichiro
  • 通讯作者:
    Takahashi, Shin-Ichiro
Effect of Paraquat-Induced Oxidative Stress on Insulin Regulation of Insulin-Like Growth Factor-Binding Protein-1 Gene Expression
Phosphatidylinositol 3-Kinase-Binding Protein, PI3KAP/XB130, Is Required for cAMP-induced Amplification of IGF Mitogenic Activity in FRTL-5 Thyroid Cells
  • DOI:
    10.1210/me.2011-1349
  • 发表时间:
    2012-06-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yamanaka, Daisuke;Akama, Takeshi;Takahashi, Shin-Ichiro
  • 通讯作者:
    Takahashi, Shin-Ichiro
Novel missense mutation in the IGF-I receptor L2 domain results in intrauterine and postnatal growth retardation
  • DOI:
    10.1111/j.1365-2265.2012.04357.x
  • 发表时间:
    2012-08-01
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Kawashima, Yuki;Higaki, Katsumi;Kanzaki, Susumu
  • 通讯作者:
    Kanzaki, Susumu
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HAKUNO Fumihiko其他文献

HAKUNO Fumihiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HAKUNO Fumihiko', 18)}}的其他基金

Clearance of insulin resistance by inhibiting diacylglycerol kinaseζ activity
通过抑制二酰甘油激酶 z 活性清除胰岛素抵抗
  • 批准号:
    19580324
  • 财政年份:
    2007
  • 资助金额:
    $ 3.16万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

骨骼肌收缩与胰岛素可能共用下游信号转导通路
  • 批准号:
    30500252
  • 批准年份:
    2005
  • 资助金额:
    26.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Development of a RUVBL1/2 Inhibitor as a Radiosensitizer and Immune Stimulator for NSCLC
开发 RUVBL1/2 抑制剂作为 NSCLC 的放射增敏剂和免疫刺激剂
  • 批准号:
    10733863
  • 财政年份:
    2023
  • 资助金额:
    $ 3.16万
  • 项目类别:
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
PI 3 激酶和 AKT 通路在癌症中的发现、调节和功能
  • 批准号:
    10246864
  • 财政年份:
    2020
  • 资助金额:
    $ 3.16万
  • 项目类别:
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
PI 3 激酶和 AKT 通路在癌症中的发现、调节和功能
  • 批准号:
    10677761
  • 财政年份:
    2020
  • 资助金额:
    $ 3.16万
  • 项目类别:
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
PI 3 激酶和 AKT 通路在癌症中的发现、调节和功能
  • 批准号:
    10471296
  • 财政年份:
    2020
  • 资助金额:
    $ 3.16万
  • 项目类别:
Designing modulators of PI 3-kinase delta (PI3Kdelta) for the treatment of haematological malignancies
设计用于治疗血液恶性肿瘤的 PI 3 激酶 δ (PI3Kdelta) 调节剂
  • 批准号:
    MC_PC_MR/S02607X/1
  • 财政年份:
    2019
  • 资助金额:
    $ 3.16万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了